☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Solid Tumor
Impact Receives US FDA's IND Clearance for IMP9064 to Treat Solid Tumor
October 29, 2021
Exclusive Interview with PharmaShots: Jonathan Benjamin of Atreca Share Insight on the Data of ATRC-101 to Treat Solid Tumor
October 22, 2021
Merck Signs an Exclusive Worldwide License Agreement with Artiva to Develop CAR-NK Cell Therapies
January 29, 2021
BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002
August 17, 2020
BioInvent Reports the Enrollment of First Patient in P-I/IIa Study of BI-1206 + Keytruda for Solid Tumors
June 23, 2020
Tilt Biotherapeutics Signs an Agreement with Merck KGaA and Pfizer to Investigate the Dual Combination for Solid Tumors
June 26, 2019
Load more...
Back to Home